View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

THOR Industries Announces Regular Quarterly Dividend

THOR Industries Announces Regular Quarterly Dividend ELKHART, Ind., Oct. 08, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that its Board of Directors approved, at its October 8, 2025, meeting, the payment of a regular quarterly cash dividend of $0.52 per share. The regular cash dividend is payable on November 6, 2025, to shareholders of record at the close of business on October 23, 2025. About THOR Industries, Inc. THOR is the sole owner of operating companies which, combined, represent the world's largest manufacturer of recreational vehicles. For more ...

 PRESS RELEASE

THOR Industries Announces Fiscal 2025 Fourth Quarter and Full Year Res...

THOR Industries Announces Fiscal 2025 Fourth Quarter and Full Year Results REPORTS SOLID RESULTS AMIDST IMPROVING MARKET SHARE, RETAIL SALES TRENDSFinancial Highlights              ($ in thousands, except for per share data) Three Months EndedJuly 31, Change  Fiscal Years EndedJuly 31, Change   2025   2024     2025   2024  Net Sales $2,523,783  $2,534,167  (0.4)%   $9,579,490  $10,043,408  (4.6)% Gross Profit $370,883  $401,331  (7.6)%   $1,340,641  $1,451,962  (7.7)% Gross Profit Margin %  14.7%   15.8%  (110) bps    14.0%   14.5%  (50) bps Net Income Attributable to THOR $125,757  $90,015...

 PRESS RELEASE

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose ...

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025 BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will host a virtual key opinion leader (KOL) event on Monday, October 20, 2025 at 8:00 AM ET featuring company leadership and Kyriakos Papadopoulos, MD (Co-Director of Clinical Research at START, San ...

 PRESS RELEASE

THOR Industries Announces Date for its Fiscal 2025 Fourth Quarter Earn...

THOR Industries Announces Date for its Fiscal 2025 Fourth Quarter Earnings Release ELKHART, Ind., Sept. 10, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that the date for its fiscal 2025 fourth quarter earnings release will be on Wednesday, September 24, 2025, before the market opens. Upon the release of THOR's fiscal 2025 fourth quarter earnings, the Company will concurrently publish a copy of the earnings release, a comprehensive question and answer document and a slide presentation on the Company's website. To view the quarterly earnings documents, please...

 PRESS RELEASE

TONX (Formerly Verb) Exec Chairman Featured on CNBC ‘Squawk Box’ Asia

TONX (Formerly Verb) Exec Chairman Featured on CNBC ‘Squawk Box’ Asia Explains How One Billion-User Global Messaging App Telegram Underpins Their Highly Differentiated Digital Asset Treasury Growth Strategy LAS VEGAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- TON Strategy Company (formerly Verb Technology Company Inc. VERB) (Nasdaq: TONX) (“TONX” or the “Company”), a digital asset treasury company committed to holding Toncoin ($TON), today announced that its Executive Chairman Manuel Stotz was interviewed on CNBC’s Squawk Box Asia. The interview, aired live throughout Asia on Wednesday Septemb...

 PRESS RELEASE

Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annu...

Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, President and Chief Executive Officer, will participate in 1x1 investor meetings at the H.C. Wainwright 27th Annual Global Investment Conference on Monday, September 8, 2025. An on-demand corporate presentation will be available on Sept...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: August 25, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: August 19, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: August 16, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of THOR Industries, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 12 August 2025 in which we reassessed the appropriateness of the ratings in the conte...

 PRESS RELEASE

Verb Technology Company (Nasdaq: VERB) Successfully Closes $558 Millio...

Verb Technology Company (Nasdaq: VERB) Successfully Closes $558 Million Private Placement to Launch First Publicly Listed TON Treasury Strategy Company, in Partnership with Kingsway Capital Majority of net proceeds from offering will support purchases of Toncoin, the native cryptocurrency of The Open Network (“TON”) blockchain LAS VEGAS, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Verb Technology Company, Inc. (Nasdaq: VERB) (“the Company”), today announced the successful closing of its previously announced upsized and oversubscribed $558 million private placement (“PIPE transaction”), in partner...

 PRESS RELEASE

Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results a...

Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Full data for Phase 1/2 dose expansion cohort expected by year-end 2025 - - Cash runway into the second quarter of 2026 - BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today reported financial results for the second quarter 2025, and provided a corporate update. “The second quarter was ...

 PRESS RELEASE

Verb Technology Company (Nasdaq: VERB) Announces Approximately $558 Mi...

Verb Technology Company (Nasdaq: VERB) Announces Approximately $558 Million Private Placement to Establish First Publicly Listed TON Treasury Strategy Company, in Partnership with Kingsway Capital Upsized and oversubscribed PIPE offering by Verb Technology Company Inc. (Nasdaq: VERB) expected to deliver approximately $558 million in gross proceedsCompany is expected to create the first publicly traded treasury reserve of Toncoin, the native cryptocurrency of The Open Network blockchain, which has an exclusive partnership with Telegram, the world’s second largest messenger with over one bill...

 PRESS RELEASE

Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose ...

Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025 BOSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, announced today that clinical data from the dose expansion cohort of the Phase 1/2 trial of solnerstotug alone and in combination with Libtayo® (cemiplimab), Regeneron’s PD-1 inhibitor, will be presented in a mini oral session at the European S...

 PRESS RELEASE

FlavCity and MARKET.live Announce Major Product Launch on TikTok LIVE ...

FlavCity and MARKET.live Announce Major Product Launch on TikTok LIVE Featuring Bobby Parrish — With Exclusive Offers and a Mid-Stream Brand Announcement LOS ANGELES, July 24, 2025 (GLOBE NEWSWIRE) -- VERB Technology Company, Inc. (NASDAQ: VERB) (“VERB” or the “Company”), the force behind MARKET.live, a leading livestream social shopping platform, today announced an exclusive TikTok LIVE event produced in partnership with health and wellness brand FlavCity. The livestream will feature FlavCity founder Bobby Parrish, who will unveil the brand’s new Anytime Essentials line—a functional dail...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 19, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 12, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 5, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch